Inotiv Inc
Research Inotiv Inc (NOTV) on Bullrun: market cap USD 418.66K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNOTV
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 418.66K
- Financial periodQ1 2026
- RevenueUSD 117.65M
- Net income-USD 32.47M
- Free cash flow-USD 3.17M
- Gross margin21.0%
Valuation Snapshot
latest market cap is USD 418.66K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 513.02M | -USD 68.63M | -USD 27.07M | 23.5% | -2.11 | USD 21.74M | USD 402.12M | USD 136.03M |
| FY2024 | USD 490.74M | -USD 108.45M | -USD 29.12M | 20.9% | -4.19 | USD 21.43M | USD 393.34M | USD 170.50M |
| FY2023 | USD 572.43M | -USD 105.14M | USD 380.00K | 32.4% | -4.1 | USD 35.49M | USD 377.75M | USD 269.15M |
| FY2022 | USD 547.66M | -USD 337.02M | -USD 41.52M | n/a | -13.84 | USD 18.52M | USD 338.66M | USD 360.37M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-06-26 | USD 418.66K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 19.26M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 139.59M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 94.65M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 126.50M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.02B | n/a | n/a | n/a |
About Inotiv Inc
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Inotiv Inc's market cap?
Inotiv Inc's market capitalization is USD 418.66K.
What does Inotiv Inc do?
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line.